参考文献
1.Fan L，Strasser-Weippl K，Li J J，et al.Breast cancer in China.The lancet oncology，2014，15（7）：e279-e289.
2.Singletary SE.Surgicalmargins in patientswith early-stage breast cancer treated with breast conservation therapy.The American journal of surgery，2002，184（5）：383-393.
3.Asgeirsson K S，Rasheed T，McCulley S J，et al.Oncological and cosmetic outcomes of oncoplastic breast conserving surgery.European Journal of Surgical Oncology（EJSO），2005，31（8）：817-823.
4.Polgár C，Van Limbergen E，Pötter R，etal.Patient selection for accelerated partial-breast irradiation（APBI）after breast-conserving surgery：recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology（GEC-ESTRO）breast cancer working group based on clinical evidence（2009）.Radiotherapy and Oncology，2010，94（3）：264-273.
5.Giuliano A E，McCall L，Beitsch P，et al.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases：the American College of Surgeons Oncology Group Z0011 randomized trial.Annals of surgery，2010，252（3）：426-433.
6.Jagsi R，Jiang J，Momoh A O，et al.Trends and variation in use of breast reconstruction in patientswith breast cancer undergoingmastectomy in the United States.Journal of Clinical Oncology，2014，32（9）：919-926.
7.Bresser P JC，Seynaeve C，Van Gool A R，et al.Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.Plastic and reconstructive surgery，2006，117（6）：1675-1682.
8.Yu K D，DiG H，Wu J，et al.Development and trends of surgicalmodalities for breast cancer in China：a review of 16-year data.Annals of surgical oncology，2007，14（9）：2502-2509.
9.陈颖，陈嘉莹，李琳，等.应用游离腹部皮瓣行118例乳房重建术的单中心报告.中国癌症杂志，2013，23（8）：576-583.
10.Early Breast Cancer Trialists'Collaborative G.Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival：an overview of the randomisedtrials.Lancet，2005，365（9472）：1687-1717.
11.Hind D，Ward S，De Nigris E，et al.Hormonal therapies for early breast cancer：systematic review and economic evaluation.Health Technol Assess，2007，11（26）：Ⅲ-Ⅳ，Ⅸ-Ⅺ，1-134.
12.Jonat W，Gnant M，Boccardo F，et al.Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer：a meta-analysis.Lancet Oncol，2006，7（12）：991-996.
13.Kiess AP，McArthur HL，Mahoney K，et al.Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative，human epidermal growth factor receptor 2-positive breast cancer.Cancer，2012，118（8）：1982-1988.
14.Ryan Michael Lanning，NadeemRiaz，Monica Morrow，etal.Effectofadjuvant trastuzumab on locoregional recurrence in human epidermalgrowth factor receptor2-positive breast cancer treated with post-mastectomy radiation therapy.2013 Breast Cancer Symposium，San Francisco，USA，2013.
15.张保宁，邵志敏，乔新民.中国乳腺癌保乳治疗的前瞻性多中心研究.中华肿瘤杂志，2005，27（11）：680-684.
16.Houssami N，Turner R，Morrow M.Preoperativemagnetic resonance imaging in breast cancer：meta-analysis of surgical outcomes.Ann Surg，2013，257（2）：249-255.
17.Houssami N，Turner R，Macaskill P，et al.An individual person datameta-analysis of preoperativemagnetic resonance imaging and breast cancer recurrence.JClin Oncol，2014，32（5）：392-401.
18.Clough KB，Cuminet J，Fitoussi A，et al.Cosmetic sequelae after conservative treatment for breast cancer：classification and results of surgical treatment.Ann Plast Surg，1998，41：471-481.
19.D’Aniello C，Grimaldi L，Barbato A，etal.Cosmetic results in 242 patients treated by conservative surgery for breast cancer.Scand JPlast Reconstr Surg Hand Surg，1999，33：419-422.
20.Cochrane RA，Valasiadou P，Wilson ARM，et al.Cosmesis and satisfaction after breast-conserving surgery correlateswith the percentage of breast volume excised.Br JSurg，2003，90：1505-1509.
21.Munhoz AM，Montag E，Arruda E，et al.Assessment of immediate conservative breast surgery reconstruction：a classification system of defects revisited and an algorithm for selecting the appropriate technique.PlastReconstr Surg，2008，121：716-727.
22.Baildam AD.Oncoplastic surgery of the breast.Br JSurg，2002，89：532-533.
23.Fitoussi AD，Berry MG，FamàF，etal.Oncoplastic breast surgery for cancer：analysis of540 consecutive cases.Plast Reconstr Surg，2010，125：454-462.
24.Rietjens M，Urban CA，Rey PC，et al.Long-term oncological results of breast conservative treatmentwith oncoplastic surgery.Breast，2007，16：387-395.
25.Kronowitz SJ，Kuerer HM，Buchholz TA，et al.A management algorithm and practical oncoplastic surgical techniques for repairing partialmastectomy defects.Plast Reconstr Sur，2008，122：1631-1647.
26.Houssami N，Macaskill P，Luke Marinovich M，et al.The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy：A Meta-Analysis.Ann Surg Oncol，2014，21（3）：717-730.
27.Julian TB，Anderson SJ，Krag DN，et al.10-yr follow-up results of occult detected sentinel node disease：NSABPB-32，a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients.2013 San Antonio Breast Cancer Symposium，Texas，USA，2013.
28.Giuliano AE，Hunt KK，Ballman KV，etal.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel nodemetastasis：a randomized clinical trial.JAMA，2011，305（6）：569-575.
29.Galimberti V，Cole BF，Zurrida S，etal.Axillary dissection versus no axillary dissection in patientswith sentinel-nodemicrometastases（IBCSG 23-01）：a phase 3 randomised controlled trial.Lancet Oncol，2013，14（4）：297-305.
30.Gooch J，King TA，Stempel EM，etal.The Extentof Extracapsular Extension（ECE）may Influence the Need for Axillary Lymph Node Dissection（ALND）in Patientswith T1-T2 BreastCancer.Society of SurgicalOncology Cancer Symposium，Fairfax，USA，2014.
31.Boughey JC，Suman VJ，Mittendorf EA，et al.Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer：the ACOSOG Z1071（Alliance）clinical trial.JAMA，2013，310（14）：1455-1461.
32.Kuehn T，Bauerfeind I，Fehm T，et al.Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy（SENTINA）：a prospective，multicentre cohort study.Lancet Oncol，2013，14（7）：609-618.
33.McGuire KP，Santos JF，Cantor A，et al.Nodal Patterns of Care in Patientswith Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy：Results of a secondary analysis of TBCRC 017.2013 San Antonio Breast Cancer Symposium，Texas，USA，2013.
34.Krag D，Weaver D，Ashikaga T，etal.The sentinelnode in breast cancer：amulticenter validation study.New Eng JMed，1999，339：941-946.
35.Kern KA.Sentinel nymph nodemapping in breast cancer using subareolar injection of blue dye.JAm College Surg，1999，189：539-545.
36.Koller M，Barsuk D，Zippel D，et al.Sentinel Lymph node involvement-a prerdictor for axillary node status with breast cancer-has the time come?Eur JSurg，1998，24：166-168.
37.Singletary SE.Systemic treatment following sentinel lymph node biopsy in breast cancer：who，what，and why? JAm Coll Surg，2001，192：220-230.
38.Breslin TM，Cohen L，Sahin A，et al.Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.JClin Oncol，2000，18：3480-3486.
39.Gibson GR，Lesnikoske B-A，Yoo J，et al.A comparison of ink-directed and traditionalwhole-cavity reexcision for breast lumpectomy specimens with positivemargins.Ann Surg Oncol，2001，8：693-704.
40.Klimberg VS，Harms S，Korourian S.Assessingmargin status.Surg Oncol，1999，8：77-84.
41.Noguchi M，Minami M，Earshi M，et al.Pathologic assessment of surgicalmargins on frozen and permanent sections in breast conserving surgery.Breast Cancer，1995，2：27-33.
42.Klimberg VS，Westbrook KC，Korourian S.Use of touch preps for diagnosis and evaluation of surgicalmargins in breast cancer.Ann Surg Oncol，1998，5：220-226.
43.Cox CE，Pendas S，Ku NN，et al.Local recurrence of breast cancer after cytological evaluation of lumpectomy margins.Am Surg，1998，64：533-537.
44.Mirza NQ，Vlastos G，Meric F，et al.Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.Ann Surg Oncol，2002，9：256-265.
45.Kaplan JL，Allen RJ.Cost-based comparison between perforator flaps and TRAM flaps for breast reconstruction.Plastic Reconstructive Surg，2000，105：943-948.
46.Kroll SS.Fat necrosis in free transverse rectus abdominismyocutaneous and deep inferior epigastric perforator flaps.Plastic Reconstructive Surg，2000，106：576-583.
47.Newman LA，Kuerer HM，Hunt KK，et al.Presentation，treatment，and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction.Annals Surg Oncol，1998，5：620-626.
48.Izzo F，Thomas R，Delrio P，et al.Radiofrequency ablation of primary breast cancer.Proc Am Soc Clin Oncol，2000，19：80A.